Covid-19 roundup: OCD drug shows 31% hos­pi­tal­iza­tion re­duc­tion in plat­form tri­al; EUA for boost­er mR­NA shot im­mi­nent — re­ports

Re­searchers in­ves­ti­gat­ing re­pur­posed ther­a­pies to treat Covid-19 un­veiled a new cut of da­ta last week look­ing at how the SS­RI flu­vox­am­ine can af­fect hos­pi­tal­iza­tions from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER